Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 116.45 USD 2.49%
Market Cap: 632.3m USD
Have any thoughts about
Mesa Laboratories Inc?
Write Note

Mesa Laboratories Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mesa Laboratories Inc
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Other Current Liabilities
$15.8m
CAGR 3-Years
18%
CAGR 5-Years
29%
CAGR 10-Years
21%
Becton Dickinson and Co
NYSE:BDX
Other Current Liabilities
$6.8B
CAGR 3-Years
238%
CAGR 5-Years
117%
CAGR 10-Years
67%
Boston Scientific Corp
NYSE:BSX
Other Current Liabilities
$1B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Other Current Liabilities
$699m
CAGR 3-Years
5%
CAGR 5-Years
19%
CAGR 10-Years
3%
Abbott Laboratories
NYSE:ABT
Other Current Liabilities
$1.6B
CAGR 3-Years
10%
CAGR 5-Years
20%
CAGR 10-Years
-3%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Current Liabilities
$590.6m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
10%
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
631.1m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
120.98 USD
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Mesa Laboratories Inc's Other Current Liabilities?
Other Current Liabilities
15.8m USD

Based on the financial report for Sep 30, 2024, Mesa Laboratories Inc's Other Current Liabilities amounts to 15.8m USD.

What is Mesa Laboratories Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
21%

Over the last year, the Other Current Liabilities growth was 7%. The average annual Other Current Liabilities growth rates for Mesa Laboratories Inc have been 18% over the past three years , 29% over the past five years , and 21% over the past ten years .

Back to Top